TRPV4 and myocardial infarction: Activation of TRPV4 is involved in hypoxia/reoxygenation injury and congestive cardiac failure [10], and the TRPV4 antagonist HC-067047 significantly reduced the myocardial infarction area and improved cardiac function in an ischemia–reperfusion (I/R) model [11].